<PAGE>1
0-24336
SEC FILE NUMBER
457971109
CUSIP NUMBER
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [x] Form 10-Q [ ] Form N-SAR
For Period Ended: March 31, 1997
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: N/A
Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
N/A
Part I-Registrant Information
- -----------------------------
Full Name of Registrant:
InPhyNet Medical Management Inc.
Former Name if Applicable:
N/A
Address of Principal Executive Office (Street and Number):
1200 South Pine Road, Suite 600
City, State and Zip Code
Fort Lauderdale, Florida 33324-4460
<PAGE>2
Part II-Rules 12b-25 (b) and (c)
- --------------------------------
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate):
(a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort
or expense;
(b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion
[X] thereof will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q, or
portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
Part III-Narrative
- ------------------
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q,
N-SAR or the transition report or portion thereof could not be filed within the
prescribed time period.
The Company is currently in discussions with representatives from the
Securities and Exchange Commission ("SEC") regarding the resolution of
accounting issues which would affect the preparation of its financial statements
for the quarter ended March 31, 1997. The Company is awaiting resolution of
these issues. Unreasonable effort and expense would be required to resolve these
issues and to prepare the Company's financial statements on a timely basis.
Accordingly, the Company respectively requests that it be granted a five
calendar day extension for the filing of its quarterly report on Form 10-Q for
the period ended March 31, 1997.
Part IV-Other Information
- -------------------------
(1) Name and telephone number of person to contact in regard to this
notification
George W. McCleary, Jr. (954) 475-1300
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d)
of the Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
<PAGE>3
[x] Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[ ] Yes [x] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
InPhyNet Medical Management Inc.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: 5/16/97 By: /s/ George W. McCleary, Jr.
Name: George W. McCleary, Jr.
Title: Executive Vice President and
Chief Financial Officer
